Alprazolam C-iv Tablet
Product Images NDC 72189-442

3 FDA label images from Direct_rx · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Alprazolam C-iv (NDC 72189-442). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Direct_rx, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

72189-392-90 (72189 442 90)

72189-392-90 (72189 442 90)
Label for Alprazolam C-IV 0.5 mg oral tablets, packaged in a quantity of 90. The label states it is generic for Xanax and contains 0.5 mg of alprazolam per tablet. It is packaged and distributed by Direct Rx, with NDC 72189-442-90. Additional details include lot number SAMPLE, expiration date 5/31/24, and a caution about proper use and storage.*
FDA Label Image

72189-442-30 (72189 442 30)

72189-442-30 (72189 442 30)
Alprazolam C-IV 0.5 mg oral tablets packaged in a label displaying 30 tablets per bottle. The label includes the product name, strength, quantity, and indicates it is generic for Xanax. The labeler is Direct_Rx with NDC 72189-442. The label also includes lot number, expiration date, and manufacturing details.*
FDA Label Image

72189-442-02 (72189 442 02)

72189-442-02 (72189 442 02)
Bottle label for Alprazolam C-IV 0.5 mg tablets by Direct Rx. The label indicates 2 tablets per package, with each tablet containing 0.5 mg Alprazolam USP. It includes lot number 02JU2508 and discard date 11/30/27. The label has warnings about federal law and storage instructions, plus distributor and manufacturing details, including NDC 72189-442-02.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.